EGR2 Gene (Early Growth Response 2)
Introduction
Egr2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">EGR2 Gene</th></tr>
<tr><td><strong>Symbol</strong></td><td>EGR2</td></tr>
<tr><td><strong>Full Name</strong></td><td>Early Growth Response 2 (Krox-20)</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>10q21.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/1960" target="_blank">1960</a></td></tr>
<tr><td><strong>OMIM</strong></td><td><a href="https://www.omim.org/entry/129010" target="_blank">129010</a></td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000122877</td></tr>
<tr><td><strong>UniProt</strong></td><td><a href="https://www.uniprot.org/uniprot/P33905" target="_blank">P33905</a></td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Charcot-Marie-Tooth Disease Type 1D, Congenital Hypomyotonia, [Alzheimer's Disease](/diseases/alzheimers-disease), ALS</td></tr>
</table>
</div>
Overview
The EGR2 gene encodes the Early Growth Response 2 protein (EGR2), also known as Krox-20. EGR2 is a zinc-finger transcription factor that plays critical roles in development, myelination, and cellular stress responses. Mutations in EGR2 cause hereditary neuropathy, and dysregulation is implicated in neurodegenerative diseases[@warner1998].
Function
Transcriptional Regulation
EGR2 regulates gene expression by:
- Binding to GC-rich DNA sequences (EGR consensus: GCGG/TGGGCG)
- Recruiting co-activators and co-repressors
- Controlling development-specific gene programs
- Responding to extracellular signals
Myelination
EGR2 is essential for:
- Peripheral nerve myelination
- Schwann cell differentiation
- Myelin gene expression (PMP22, MPZ, MBP)
- Maintenance of myelin integrity
Neuronal Function
In the central nervous system:
- Regulates neuronal differentiation
- Controls synaptic plasticity
- Mediates stress responses
- Modulates circadian rhythm
Disease Associations
Charcot-Marie-Tooth Disease
- EGR2 mutations cause CMT1D
- Autosomal dominant or recessive inheritance
- Peripheral demyelinating neuropathy
- Onset in childhood or adolescence[@svaren2008]
Congenital Hypomyotonia
- Mutations cause severe neonatal hypotonia
- Delayed motor development
- Often associated with arthrogryposis
Alzheimer's Disease
- EGR2 expression altered in AD brains
- May regulate [APP](/entities/app-protein) processing
- Involved in neuronal survival
- Potential therapeutic target[@poirier2014]
ALS
- EGR2 dysregulated in ALS motor [neurons](/entities/neurons)
- May affect gene expression in disease
- Potential biomarker
Expression Pattern
| Tissue | Expression Level |
|--------|------------------|
| Peripheral nerve | Very High (Schwann cells) |
| Spinal Cord | Moderate |
| Brain | Moderate |
| Retina | Moderate |
| Lung | Low |
Research Directions
- Gene therapy for CMT1D
- Understanding myelination mechanisms
- EGR2 in neurodegeneration
- Transcriptional therapy
Key Publications
[@warner1998]: Warner LE, Mancias P, Butler IJ, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet. 1998;18(4):382-384.
[@svaren2008]: Svaren J, Meijer D. The molecular machinery of myelin gene transcription in Schwann cells. Glia. 2008;56(14):1541-1551.
[@poirier2014]: Poirier R, Veylat C, Bourhis A, et al. Distinct neuronal networks mediate Egr1 expression in the prefrontal [cortex](/brain-regions/cortex) and hippocampus. [Hippocampus](/brain-regions/hippocampus). 2014;24(10):1184-1197.
See Also
- [EGR1 Gene](/proteins/egr1-protein)
- [Myelin Protein](/proteins/myelin-protein)
- [Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [ALS](/diseases/als)
External Links
- [NCBI Gene: EGR2](https://www.ncbi.nlm.nih.gov/gene/1960)
- [UniProt: P33905](https://www.uniprot.org/uniprot/P33905)
- [OMIM: 129010](https://www.omim.org/entry/129010)
Expression Pattern
EGR2 is expressed in developing nervous system, peripheral nervous system, immune system, and some brain regions. Critical for development.
Molecular Mechanisms
Transcription Factor
EGR2 (Krox-20) binds to GC-rich DNA sequences, regulates development genes, and controls myelination.
Peripheral Myelination
EGR2 is essential for Schwann cell myelination.
Role in Neurodegeneration
Charcot-Marie-Tooth Disease
EGR2 mutations cause CMT1A-like neuropathy (PubMed: 21458745).
Alzheimer's Disease
EGR2 may be involved in neuronal survival pathways.
Demyelinating Diseases
EGR2 dysregulation affects myelin maintenance.
Therapeutic Implications
Understanding myelination and CMT treatment approaches are areas of active research.
Background
The study of Egr2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Warner LE, Mancias P, Butler IJ, et al, Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies (1998)
Svaren J, Meijer D, The molecular machinery of myelin gene transcription in Schwann cells (2008)
Poirier R, Veylat C, Bourhis A, et al, Distinct neuronal networks mediate Egr1 expression in the prefrontal [cortex](/brain-regions/cortex) and hippocampus (2014)Pathway Diagram
The following diagram shows the key molecular relationships involving egr2 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Pathway Diagram
The following diagram shows the key molecular relationships involving EGR2 Gene (Early Growth Response 2) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)